Systematic Financial Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.74M | Buy |
245,545
+79,041
| +47% | +$2.49M | 0.21% | 135 |
|
|
2025
Q1 | $5.45M | Buy |
166,504
+53,004
| +47% | +$1.74M | 0.16% | 149 |
|
|
2024
Q4 | $4.1M | Buy |
113,500
+85,315
| +303% | +$3.08M | 0.1% | 159 |
|
|
2024
Q3 | $879K | Buy |
+28,185
| New | +$879K | 0.02% | 225 |
|
|
2020
Q3 | – | Sell |
-14,110
| Closed | -$335K | – | 425 |
|
|
2020
Q2 | $335K | Sell |
14,110
-7,470
| -35% | -$177K | 0.02% | 246 |
|
|
2020
Q1 | $388K | Sell |
21,580
-6,085
| -22% | -$109K | 0.02% | 230 |
|
|
2019
Q4 | $656K | Buy |
27,665
+9,280
| +50% | +$220K | 0.03% | 256 |
|
|
2019
Q3 | $505K | Sell |
18,385
-10,900
| -37% | -$299K | 0.02% | 397 |
|
|
2019
Q2 | $969K | Buy |
+29,285
| New | +$969K | 0.04% | 296 |
|